Back to search

Article

Nanochips assisted peptide screening for clinical development of CAR-T cell immunotherapy

2021-08-26

Abstract excerpt

<title>Abstract</title> <p>Immunotherapy using CAR-T cells is a new paradigm technology for cancer treatment. To avoid severe side effects and tumor escape variants observed for conventional CAR-T cells approach, adaptor CAR technologies are under development, where intermediate target modules redirect immune cells against cancer. In this work, silicon nanowire field effect transistors are used to assist in the d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ef418fed-35cb-58bb-9d58-a6c3a1ba1392
DOI
10.21203/rs.3.rs-841987/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nanochips assisted peptide screening for clinical development of CAR-T cell immunotherapyDOI 10.21203/rs.3.rs-841987/v1
The Application of Nanobody in CAR-T TherapySemantic proximity
Self-assembled peptide/polymer hybrid nanoplatform for cancer immunostimulating therapiesSemantic proximity
High-throughput screening of functional neo-antigens and their specific TCRs via the Jurkat reporter system combined with droplet microfluidicsSemantic proximity
Nanomedicine for Cancer and Autoimmune ImmunotherapySemantic proximity
Diagnostic Devices for Circulating Biomarkers Detection and Quantification.Semantic proximity
T cell circuits that sense antigen density with an ultrasensitive thresholdSemantic proximity
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapySemantic proximity
Nanobody-based CAR-T cells for cancer immunotherapySemantic proximity
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer ImmunotherapySemantic proximity
Enhancing Patient Lymphocyte Response to Peritoneal Malignancies Using a Personalized Immunocompetent Microfluidic Co-Culture PlatformSemantic proximity
Optimising CAR-T cell sensitivity by engineering matched extracellular sizes between CAR/antigen and CD2/CD58 adhesion complexesSemantic proximity
Recent Advances on Affibody- and DARPin-Conjugated Nanomaterials in Cancer TherapySemantic proximity
Select a neighboring publication to make it the new centre.